Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
ZypAdhera ® (olanzapine pamoate monohydrate)
ZypAdhera® (olanzapine pamoate): Injection Site
Olanzapine pamoate is for deep intramuscular gluteal injection only. Do not administer intravenously or subcutaneously.
Olanzapine pamoate should only be administered by deep intramuscular gluteal injection by a healthcare professional trained in the appropriate injection technique and in locations where post-injection observation and access to appropriate medical care in the case of overdose can be assured.1
Further label Information
insertion of the needle, aspirate for several seconds to ensure no
blood appears. If any blood is drawn into the syringe, discard the
syringe and the dose and begin reconstitution and administration
The injection should be performed with steady, continuous pressure.1
DO NOT MASSAGE THE INJECTION SITE.1
2. Beyea SC, Nicoll LH. Administration of medications via the intramuscular route: an integrative review of the literature and research-based protocol for the procedure. Appl Nurs Res. 1995;8(1):23-33. http://dx.doi.org/10.1016/S0897-1897(95)80279-7
Date of Last Review: May 01, 2019